HbA1c falls where it starts high, and the glucose effect saturates below the weight dose: doubling from 1.0 to 2.0 mg added only about 0.2 points of HbA1c while still adding weight loss
KN has received honoraria from AstraZeneca, Bayer, Boehringer Ingelheim Japan, Daiichi Sankyo, Eli Lilly Japan, Kowa, Mitsubishi Tanabe, MSD, Novartis, Novo Nordisk, and Otsuka
While interactions exist in theory, recent data suggests that semaglutide does not significantly impact SSRI efficiency
[9] [25] Patients should be alert to symptoms such as right upper quadrant pain, fever, or jaundice, which warrant urgent medical attention
Alcoholic liver disease presents an interesting case
Additionally, patients should have regular thyroid function monitoring, as weight loss itself can sometimes necessitate adjustments to levothyroxine dosing